Last reviewed · How we verify
NCT07222033
Self-balancing Personal Exoskeleton for SCI (WINY)
NA trial testing Hands-free exoskeleton in Spinal Cord Injury in 12 participants. Currently enrolling.
31 May 2026
Quick facts
| Lead sponsor | Wandercraft |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 11 August 2025 |
| Primary completion | 31 May 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hands-free exoskeleton
Conditions studied
- Spinal Cord Injury — all drugs for Spinal Cord Injury →
- Paraplegia and Tetraplegia — all drugs for Paraplegia and Tetraplegia →
Sponsor
Wandercraft
Who can join
18 and older, any sex, with Spinal Cord Injury or Paraplegia and Tetraplegia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07222033
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hands-free exoskeleton
Trials testing the same drug.
- NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting
- NCT06814015 — Self-balancing Personal Exoskeleton for SCI (Site 2) · NA · recruiting
- NCT06777576 — Self-balancing Personal Exoskeleton for SCI · NA · recruiting
- NCT06715631 — Human Factors Validation Testing of the Wandercraft Personal Exoskeleton · NA · completed
- NCT06939634 — Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia · completed
Other recruiting trials for Spinal Cord Injury
Currently open trials in the same condition.
- NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
- NCT06410001 — CE-STAND: Cervical Epidural STimulation After Neurologic Damage · Phase 1, PHASE2 · recruiting
- NCT05926596 — Leg Stretching Using an Exoskeleton on Demand for People With Spasticity · NA · recruiting
- NCT06839300 — The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study · recruiting
- NCT07036107 — A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the S · NA · recruiting
Other Wandercraft trials
Trials by the same sponsor.
- NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting
- NCT06814015 — Self-balancing Personal Exoskeleton for SCI (Site 2) · NA · recruiting
- NCT06777576 — Self-balancing Personal Exoskeleton for SCI · NA · recruiting
- NCT06715631 — Human Factors Validation Testing of the Wandercraft Personal Exoskeleton · NA · completed
- NCT06939634 — Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07222033 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wandercraft
- Last refreshed: 2 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07222033.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing